journal article·2019-10-01Open access

Nanofiber scaffolds attenuate collagen synthesis of human dermal fibroblasts through TGF-β1/TSG-6 pathway*

Bei Xie, Wanzong Zhu, Pinghui Ding, Mengting Chen, Ji Li, Lei Lei, Can Zhang, Hemin Nie

Journal of Physics: Materials· Volume 2· Issue 4

Abstract

Abstract Nanofiber scaffolds are promising patches for skin tissue regeneration as they provide favorable environment for the adhesion, infiltration and proliferation of skin dermal fibroblasts. However, the effects of nanofiber scaffolds on scar formation remain to be elucidated. The aim of this study was to find out the relationship between nanofiber scaffolds and scar formation, along with the underlying mechanism. We found that polycaprolactone (PCL)/gelatin nanofiber scaffolds attenuated the mRNA expression of fibrosis-associated genes in fibroblasts, including collagen I (collagen type I alpha 1), collagen III (collagen type III alpha 1) and fibronectin. Specifically thicker scaffolds displayed stronger fibrosis inhibitory effect than thin scaffolds. The mechanism relied on TGF-β1/TSG-6 pathway, and overexpression of TSG-6 impaired the anti-fibrosis effect of nanofiber scaffolds, which decreased TGF-β1 expression with thickness-dependency. Moreover, in vivo study demonstrated that nanofiber scaffolds remarkably accelerated the wound healing process by reducing the ratios of collagen I/collagen III and TGF-β1, eventually decreased the deposition of collagens. Taken together, our results suggested that the attenuation of fibrosis by PCL/gelatin nanofiber scaffolds was TGF-β1-dependent and through TGF-β1/TSG-6 pathway. Nanofiber scaffold of appropriate thickness would accelerate skin wound healing, stimulate re-epithelialization and form cutaneous skin appendages in skin trauma. Thus, PCL/gelatin nanofiber scaffolds could be adopted for scar-free skin wound healing and skin cosmetics applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Wound Healing and Treatments · Periodontal Regeneration and Treatments · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (46)

Show source-provided references
1. Concise review: role of mesenchymal stem cells in wound repair10.5966/sctm.2011-0018 ↗
2. Wound healing—aiming for perfect skin regeneration10.1126/science.276.5309.75 ↗
3. Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics: I. The molecular basis of scar formation10.1016/j.jaad.2011.05.055 ↗
4. Potential cellular and molecular causes of hypertrophic scar formation10.1016/j.burns.2008.06.020 ↗
5. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies10.2119/molmed.2009.00153 ↗
6. Scar redness in humans: how long does it persist after incisional and excisional wounding?10.1097/01.prs.0000299183.88334.37 ↗
7. The fetal fibroblast: the effector cell of scarless fetal skin repair10.1097/00006534-199511000-00002 ↗
8. Advances in the modulation of cutaneous wound healing and scarring10.2165/00063030-200519060-00004 ↗
9. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring10.1242/jcs.108.3.985 ↗
10. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma10.1016/S0002-9440(10)63289-0 ↗
11. Smad-dependent and Smad-independent pathways in TGF-beta family signalling10.1038/nature02006 ↗
12. The myofibroblast in wound healing and fibrocontractive diseases10.1002/path.1427 ↗
13. Age-related changes in pericellular hyaluronan organization leads to impaired dermal fibroblast to myofibroblast differentiation10.2353/ajpath.2009.090045 ↗
14. Involvement of hyaluronan in regulation of fibroblast phenotype10.1074/jbc.M700773200 ↗
15. Tumor necrosis factor-stimulated gene 6 (TSG-6)-mediated interactions with the inter-α-inhibitor heavy chain 5 facilitate tumor growth factor β1 (TGFβ1)-dependent fibroblast to myofibroblast differentiation10.1074/jbc.M115.670521 ↗
16. Effect of hyaluronic acid (HA) in a HA/PLGA scaffold on annulus fibrosus regeneration: in vivo tests10.1007/s13233-013-1137-z ↗
17. Synergic effects of nanofiber alignment and electroactivity on myoblast differentiation10.1016/j.biomaterials.2012.05.018 ↗
18. Electrospinning: applications in drug delivery and tissue engineering10.1016/j.biomaterials.2008.01.011 ↗
19. Effect of sustained heparin release from PCL/chitosan hybrid small-diameter vascular grafts on anti-thrombogenic property and endothelialization10.1016/j.actbio.2014.02.042 ↗
20. Fabrication and characterization of six electrospun poly(alpha-hydroxy ester)-based fibrous scaffolds for tissue engineering applications10.1016/j.actbio.2006.02.005 ↗
21. Topical astragaloside IV-releasing hydrogel improves healing of skin wounds in vivo10.1248/bpb.35.881 ↗
22. Protein-based nanocarriers as promising drug and gene delivery systems10.1016/j.jconrel.2012.04.036 ↗
23. Fabrication and characterization of PCL/gelatin/chitosan ternary nanofibrous composite scaffold for tissue engineering applications10.1007/s10853-013-7785-8 ↗
24. Evaluation of electrospun PCL/gelatin nanofibrous scaffold for wound healing and layered dermal reconstitution10.1016/j.actbio.2007.01.002 ↗
25. In vitro mineralization and bone osteogenesis in poly(ε-caprolactone)/gelatin nanofibers10.1002/jbm.a.34233 ↗
26. Electrospun poly(epsilon-caprolactone)/gelatin nanofibrous scaffolds for nerve tissue engineering10.1016/j.biomaterials.2008.08.007 ↗
27. Electrospun polycaprolactone/gelatin composites with enhanced cell-matrix interactions as blood vessel endothelial layer scaffolds10.1016/j.msec.2016.10.083 ↗
28. Dual growth factor releasing multi-functional nanofibers for wound healing10.1016/j.actbio.2013.07.030 ↗
29. The effect of thick fibers and large pores of electrospun poly(ε-caprolactone) vascular grafts on macrophage polarization and arterial regeneration10.1016/j.biomaterials.2014.03.078 ↗
30. Time-programmed dual release formulation by multilayered drug-loaded nanofiber meshes10.1016/j.jconrel.2009.12.029 ↗
31. BMP-2 plasmid loaded PLGA/HAp composite scaffolds for treatment of bone defects in nude mice10.1016/j.biomaterials.2008.10.029 ↗
32. Functionalized hybrid nanofibers to mimic native ECM for tissue engineering applications10.1016/j.apsusc.2014.10.074 ↗
33. Hypertrophic scars and keloids—a review of their pathophysiology, risk factors, and therapeutic management10.1111/j.1524-4725.2008.34406.x ↗
34. On the nature of hypertrophic scars and keloids: a review10.1097/00006534-199910000-00031 ↗
35. The effect of hyaluronan on the motility of skin dermal fibroblasts in nanofibrous scaffolds10.1016/j.ijbiomac.2015.04.059 ↗
36. Salvianolic acid B attenuates experimental pulmonary fibrosis through inhibition of the TGF-β signaling pathway10.1038/srep27610 ↗
37. The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis10.1097/00006534-199610000-00012 ↗
38. Tumour necrosis factor-stimulated gene (TSG)-6 controls epithelial-mesenchymal transition of proximal tubular epithelial cells10.1016/j.biocel.2011.08.009 ↗
39. Aging fibroblasts resist phenotypic maturation because of impaired hyaluronan-dependent CD44/epidermal growth factor receptor signaling10.2353/ajpath.2010.090802 ↗
40. Transcriptional control of wound repair10.1146/annurev.cellbio.23.090506.123609 ↗
41. Calcium alginate enhances wound healing by up-regulating the ratio of collagen types I/III in diabetic rats
42. A conducive bioceramic/polymer composite biomaterial for diabetic wound healing10.1016/j.actbio.2017.07.020 ↗
43. Human amniotic epithelial cells attenuate TGF-β1-induced human dermal fibroblast transformation to myofibroblasts via TGF-β1/Smad3 pathway10.1016/j.jcyt.2016.04.009 ↗
44. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway10.1111/exd.12665 ↗
45. Cross-talk between TGF-β/Smad pathway and Wnt/β-catenin pathway in pathological scar formation
46. The chronic wound: impaired healing and solutions in the context of wound bed preparation10.1016/j.bcmd.2003.09.020 ↗